Breakthrough treatment for Obstructive Sleep Apnea now offered at BMC
If you or a loved one suffers from Obstructive Sleep Apnea (OSA) you know how difficult it can be to manage. On top of the serious health risks associated with OSA, like weight gain, high blood pressure, and increased risk of stroke – the excessive daytime sleepiness, loud snoring, and mood swings are no fun, either. Today, more than 18 million American’s currently suffer from this condition. While the Continuous Positive Airway Pressure machine – or CPAP – is a common device used for treatment, studies have shown that approximately half of people who use CPAP, eventually stop.
Luckily, patients at Boston Medical Center have a new option to manage their OSA. Inspire® therapy is an FDA-approved, breakthrough treatment that can bring relief to those unable to use CPAP. This minimally invasive, implantable device stimulates the nerves of the tongue muscle, keeping the airway open during sleep. The device is the size of a quarter and implanted just beneath the skin of the chest. The procedure is quick, simple, and most patients return home that same day. When it’s time for bed, the patient turns Inspire® on with a small remote, and their breathing is monitored throughout the duration of sleep.
Is Inspire® therapy right for you? You may be a candidate if you:
- have moderate to severe Obstructive Sleep Apnea
- are unable to use or get consistent benefit from CPAP
- are over the age of 22
- are not significantly overweight
To learn more about this breakthrough treatment, visit bmc.org/oto, or call 617.414.5105.
Listen in as Dr. Cohen discusses symptoms of OSA, and this new groundbreaking therapy to help.